CA2325087A1 - Glucosides de sterol dans une maladie - Google Patents
Glucosides de sterol dans une maladie Download PDFInfo
- Publication number
- CA2325087A1 CA2325087A1 CA002325087A CA2325087A CA2325087A1 CA 2325087 A1 CA2325087 A1 CA 2325087A1 CA 002325087 A CA002325087 A CA 002325087A CA 2325087 A CA2325087 A CA 2325087A CA 2325087 A1 CA2325087 A1 CA 2325087A1
- Authority
- CA
- Canada
- Prior art keywords
- glutamate
- cycad
- mso
- gsh
- als
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002325087A CA2325087A1 (fr) | 2000-11-03 | 2000-11-03 | Glucosides de sterol dans une maladie |
DK01992897.7T DK1334368T5 (en) | 2000-11-03 | 2001-11-02 | Sterolglykosidtoksiner |
AU2002223317A AU2002223317A1 (en) | 2000-11-03 | 2001-11-02 | Sterol glucoside toxins |
CA2464232A CA2464232C (fr) | 2000-11-03 | 2001-11-02 | Toxines de sterol glucoside |
EP01992897.7A EP1334368B1 (fr) | 2000-11-03 | 2001-11-02 | Toxines de sterol glucoside |
PCT/CA2001/001567 WO2002037122A2 (fr) | 2000-11-03 | 2001-11-02 | Toxines de sterol glucoside |
US10/415,710 US20040048810A1 (en) | 2000-11-03 | 2001-11-02 | Sterol glucoside toxins |
US11/477,730 US8148336B2 (en) | 2000-11-03 | 2006-06-29 | Sterol glucoside toxins |
US13/435,825 US8497123B2 (en) | 2000-11-03 | 2012-03-30 | Sterol glucoside toxins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002325087A CA2325087A1 (fr) | 2000-11-03 | 2000-11-03 | Glucosides de sterol dans une maladie |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2325087A1 true CA2325087A1 (fr) | 2002-05-03 |
Family
ID=4167548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002325087A Abandoned CA2325087A1 (fr) | 2000-11-03 | 2000-11-03 | Glucosides de sterol dans une maladie |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2325087A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010048710A1 (fr) * | 2008-10-31 | 2010-05-06 | Neurodyn, Inc. | Glycosides de stérol neurotoxiques |
CN109122831A (zh) * | 2018-07-05 | 2019-01-04 | 中国热带农业科学院农产品加工研究所 | 一种番荔枝鲜果保鲜剂及其制备方法 |
-
2000
- 2000-11-03 CA CA002325087A patent/CA2325087A1/fr not_active Abandoned
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010048710A1 (fr) * | 2008-10-31 | 2010-05-06 | Neurodyn, Inc. | Glycosides de stérol neurotoxiques |
CN102272321A (zh) * | 2008-10-31 | 2011-12-07 | 神经动力公司 | 神经毒性甾醇糖苷 |
US9573972B2 (en) | 2008-10-31 | 2017-02-21 | Neurodyn, Inc. | Nurotoxic sterol glycosides |
CN109122831A (zh) * | 2018-07-05 | 2019-01-04 | 中国热带农业科学院农产品加工研究所 | 一种番荔枝鲜果保鲜剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8148336B2 (en) | Sterol glucoside toxins | |
Khabazian et al. | Isolation of various forms of sterol β‐d‐glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS‐parkinsonism dementia complex | |
Rosemberg et al. | Taurine prevents enhancement of acetylcholinesterase activity induced by acute ethanol exposure and decreases the level of markers of oxidative stress in zebrafish brain | |
Wilson et al. | Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour | |
Bloomer | Effect of exercise on oxidative stress biomarkers | |
Czerniczyniec et al. | Paraquat induces behavioral changes and cortical and striatal mitochondrial dysfunction | |
Yadav et al. | Mucuna pruriens seed extract reduces oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in paraquat-induced Parkinsonian mouse model | |
Kucukatay et al. | Effect of sulfur dioxide on active and passive avoidance in experimental diabetes mellitus: relation to oxidant stress and antioxidant enzymes | |
Cunningham et al. | HIGH INTENSITY SPRINT TRAINING REDUCES LIPID PEROXIDATION IN FAST-TWITCH SKELETAL MUSCLE. | |
KR20080066802A (ko) | 간 건강 개선을 위한 식물성 제형물 | |
Marshall et al. | The neuronal toxicity of sulfite plus peroxynitrite is enhancede by glutathione depletion: implications for Parkinson’s disease | |
Moothoo-Padayachie et al. | Germination associated ROS production and glutathione redox capacity in two recalcitrant-seeded species differing in seed longevity | |
Shapiro et al. | Characterization of demethylation of methylmercury in cultured astrocytes | |
Olofsson et al. | Glucose-induced cataract in CuZn-SOD null lenses: an effect of nitric oxide? | |
Almeida et al. | Postnatal development of the complexes of the electron transport chain in synaptic mitochondria from rat brain | |
Yargicoglu et al. | The effect of sulfur dioxide inhalation on active avoidance learning, antioxidant status and lipid peroxidation during aging | |
CA2325087A1 (fr) | Glucosides de sterol dans une maladie | |
Arakawa et al. | N-Acetylcysteine and ebselen but not nifedipine protected cerebellar granule neurons against 4-hydroxynonenal-induced neuronal death | |
Rawling et al. | Lung poly (ADP-ribose) and NAD+ concentrations during hyperoxia and niacin deficiency in the Fischer-344 rat | |
Horemans et al. | Transport of ascorbate into protoplasts of Nicotiana tabacum Bright Yellow-2 cell line | |
Pepe | The effects of gender and exercise on malondialdehyde, nitric oxide and total glutathione levels in rat liver | |
CA2342085A1 (fr) | Sterol-glucosides toxiques | |
Cavallini et al. | Effects of chemical ischemia in cerebral córtex slices: focus on nitric oxide | |
CA2464232C (fr) | Toxines de sterol glucoside | |
Unger et al. | Acoustic startle response is disrupted in iron-deficient rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |